Contrast-Enhanced Spectral Mammography Versus Magnetic Resonance Imaging: Intra- and Inter-Observer Agreements in Tumour Size AssessmentOriginal Article • March 27th, 2024
Contract Type FiledMarch 27th, 2024Introduction: In patients with locally advanced breast carcinomas undergoing neoadjuvant chemotherapy (NAC), imaging monitoring is important for guiding clinical management. Contrast-enhanced spectral mammography (CESM) is a recently introduced modality that may serve this purpose as an alternative to magnetic resonance imaging (MRI). We aimed to investigate intra- and inter-observer agreements in CESM and MRI in assessment of tumour size.
Contrast-Enhanced Spectral Mammography Versus Magnetic Resonance Imaging: Intra- and Inter-Observer Agreements in Tumour Size AssessmentOriginal Article • March 19th, 2024
Contract Type FiledMarch 19th, 2024Introduction: In patients with locally advanced breast carcinomas undergoing neoadjuvant chemotherapy (NAC), imaging monitoring is important for guiding clinical management. Contrast-enhanced spectral mammography (CESM) is a recently introduced modality that may serve this purpose as an alternative to magnetic resonance imaging (MRI). We aimed to investigate intra- and inter-observer agreements in CESM and MRI in assessment of tumour size.